Related Experiment Video
Updated: Jul 19, 2026
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early intervention after
Lu Huang1,2, Li Xia1,3, Tiejian Nie1
1Department of Experimental Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, Shaanxi, China.
Abstract:
Traumatic brain injury (TBI) is a major cause of death and disability in adults. The pathological process of TBI involves a multifactorial cascade in which kinases have been proven contribute to interactions between relevant factors and amplification of signaling cascades. Cyclin-dependent kinase 5 (Cdk5) is a promising kinase that has been implicated in various brain disorders, including TBI. However, the mechanism by which Cdk5 induces neuronal damage remains unclear. Here, we show for the first time that Drosha, a key enzyme in microRNA biogenesis, is a pivotal substrate of abnormally activated Cdk5. Cdk5-mediated phosphorylation decreases Drosha expression and exacerbates nerve injury in TBI. We proved that maintaining Drosha expression via the administration of repurposed Cdk5 inhibitors that were previously studied in clinical trials is a promising approach for the early treatment of TBI. Together, our work identifies Drosha as a novel target for neuroprotective strategies after TBI and suggests Cdk5-mediated regulation of Drosha expression as a potential therapeutic strategy for early TBI intervention.
Insights
Cyclin-dependent kinase 5 (Cdk5) abnormally activates Drosha, a microRNA enzyme, worsening traumatic brain injury (TBI) nerve damage. Cdk5 inhibitors may offer early TBI neuroprotection by maintaining Drosha expression.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Traumatic brain injury (TBI) is a leading cause of adult death and disability.
- Kinases play a key role in TBI's complex pathological cascade.
- Cyclin-dependent kinase 5 (Cdk5) is implicated in brain disorders, including TBI, but its precise role in neuronal damage is unknown.
Purpose of the Study:
- To elucidate the mechanism of Cdk5-induced neuronal damage in TBI.
- To identify novel therapeutic targets for TBI intervention.
Main Methods:
- Investigated the interaction between Cdk5 and Drosha in TBI.
- Examined the effect of Cdk5-mediated phosphorylation on Drosha expression.
- Evaluated the therapeutic potential of Cdk5 inhibitors in a TBI model.
Main Results:
- Demonstrated that Drosha is a substrate of abnormally activated Cdk5 in TBI.
- Showed that Cdk5-mediated phosphorylation decreases Drosha expression, exacerbating nerve injury.
- Confirmed that maintaining Drosha expression using repurposed Cdk5 inhibitors is a promising early TBI treatment.
Conclusions:
- Identified Drosha as a novel therapeutic target for neuroprotection in TBI.
- Established Cdk5-mediated regulation of Drosha expression as a potential strategy for early TBI intervention.
More Related Videos
09:29Controlled Cortical Impact Model of Mouse Brain Injury with Therapeutic Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Cells
Published on: July 10, 2019
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Related Concept Videos
02:34Inhibition of Cdk Activity
01:28Traumatic Brain Injury l: Introduction